Organon

Organon has a mission to deliver impactful medicines and solutions for a healthier every day. We build upon our strong foundation of more than 60 medicines and other products across a range of areas including reproductive health, heart disease, dermatology, allergy and asthma. We bring these important therapies around the world, with an international footprint that serves people in more than 140 markets. We believe the diversity of our business provides a sustainable engine of growth so we can continue to invest in and advance new medicines and treatments for women that are so urgently needed. We are here for her health.

Alliance Pharmaceuticals

Alliance Pharmaceuticals Ltd is delighted to support Primary Care Nursing Live 2024.
Alliance is a leading international healthcare business of interconnected people and brands. Our purpose is to help improve the lives of consumers and patients through a range of various healthcare products. Every day, we work with our partners and colleagues around the globe, to maximise the value of our products and help make a real difference in people’s lives. The range of products we supply spans a wide variety of therapeutic areas, including nutritional supplements for those with dietary deficiencies.
For more information about our company please visit www.alliancepharmaceuticals.com. You can contact us by email at info@alliancepharma.co.uk, or call us on 01249 466966.

Chiesi

Based in Parma, Italy, Chiesi Farmaceutici is an international research-focused biopharmaceuticals group with over 85 years’ experience in the pharmaceutical sector operating in 30 countries, employing around 6,000 people. The Group’s research and development centre in Parma works alongside six other important R&D hubs in France, the US, Canada, China, the UK, and Sweden. Chiesi develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. The company’s mission is to improve people’s quality of life and act responsibly towards both the community and the environment. As a certified B Corp since 2019, Chiesi is part of a global community of businesses that meet high standards of social and environmental impact. The company aims at becoming net-zero by 2035. Chiesi Limited is headquartered in Manchester and employs over 400 people. Further information: www.chiesi.uk.com

(Some industry partners have sponsored this meeting via the provision of
promotional exhibition stands and/or promotional symposia. They have had no influence on the rest of the meeting’s agenda or speakers)

GSK

GSK are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in new commitments to growth and a step-change in performance.

CoppaFeel!

CoppaFeel! are the first breast cancer charity in the UK to solely create awareness amongst young people. We want to educate young people on the signs and symptoms of breast cancer, encourage them to be regularly checking their boobs, pecs or chest from a young age and empower them to seek advice if they notice a change. We work with nurses and other healthcare professionals to support them in advocating for our mission and spreading vital patient education.

Data4NHS

Data4NHS maintains one of the largest healthcare related databases in the UK.  Formerly known as the Blue Book, Data4NHS has been compiling data on the NHS since 1992. This established and trusted resource contains up-to-date, accurate and in-depth information relating to a variety of healthcare professionals working for and supporting the NHS.  Registration is free and only available to NHS professionals with a valid NHS email address.  Register with us to have access to our resources including the Data4NHS national directory, recruitment opportunities, events and courses calendar, surveys and e-bulletin.

Gedeon Richter

Gedeon Richter have a presence in over 100 countries worldwide and have been working to change lives for the better since 1901. We are one of the few companies in the world to offer a comprehensive portfolio for women; our R&D team continue to innovate and extend our gynaecological, fertility and osteoporosis portfolio, aiming to address women’s healthcare needs in these areas. Our ambition is to help women achieve theirs.

TriOn Pharma

TriOn Pharma is a dynamic UK-based company specializing in Nutraceuticals, Pharmaceuticals, and Medical Devices. Our focus centers on the exploration and development of innovative, high-quality, and cost-effective products designed to enhance the health and well-being of individuals. As an ethical pharmaceutical company, we play a vital role in supporting the NHS by optimizing drug budgets while steadfastly upholding quality standards. Our commitment lies in providing solutions that contribute to significant cost savings for the NHS without any compromise on the excellence of our products.

Trudell Medical

Trudell Medical International works with patients, their caregivers and healthcare professionals to help patients all over the world breathe better and fuller lives. We manufacture and globally market some of the leading brands in respiratory care including the AeroChamber* brand of spacers, Aerobika* OPEP devices, and AeroEclipse* BAN* nebulisers."

Pfizer

Pfizer Vaccines: Protecting life’s journey.

Our history in vaccines stretches as far back as 1882. Today, our organisation is comprised of passionate, world-class employees who work every day to translate cutting-edge science into vaccines that improve people’s lives.
We have a portfolio of vaccines that helps protect individuals from serious diseases at every stage of life, from the first months to old age.

Agamatrix

The WaveSense JAZZ™ test strip has been a popular choice of Commissioners and HCPs for many years, resulting in it being the 2nd most prescribed test strip in the UK.  AgaMatrix have worked hard to secure this position by offering high quality, accurate blood glucose testing combined with second-to-none support.
AgaMatrix are pleased to have the additional endorsement of the JAZZ™ meters being recommended by NHS England in their commissioning recommendations for blood and ketone meters, together with our new Agile™ meter.
Visit the AgaMatrix stand to find out more about the Agile™ meter product launch and the recently launched ALLY™ Diabetes Management System.  The system consists of ALLY Home for patients and ALLY for GP Practices and Community Diabetes Teams that enable the sharing of data for easier diabetes management.

Symprove

Symprove is a water-based probiotic that delivers billions of live and active bacteria to the gut.  The healthy bacteria arrive safely in the gut, surviving the harsh environment of the stomach, before multiplying rapidly, thriving and colonising in the gut. This process has been scientifically proven by independent clinical trials in collaboration with research partners including University College London and King’s College London. With existing studies in IBS and IBD completed, Symprove and its key research partners have several more studies underway, including new research on IBS, which will be published in 2024.

Having gained an impressive and loyal customer base since its launch to the market (9 out of 10 customers would recommend), alongside backing from clinical experts, Symprove allows people to take control of their gut and currently boasts an impressive 4.5* TrustPilot score.

The product is vegan, gluten free and FODMAP-friendly.

Crohn's and Colitis

We’re the UK’s leading charity for Crohn’s and Colitis. Right now, an estimated 500,000 people in the UK are living with a lifelong disease that can profoundly affect their quality of life. And, because of the stigma surrounding these conditions, thousands of people are suffering in silence. But we are here to support and champion their cause. We want to see improved lives today, and a world free from Crohn’s and Colitis tomorrow.

Aspire Pharma

Abbott

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 115,000 colleagues serve people in more than 160 countries.

At Abbott, we believe people with diabetes should enjoy active lives, so we’re focused on making breakthrough technology accessible and approachable for all. Our groundbreaking sensing technology is revolutionising how people monitor glucose and providing healthcare professionals with more data to make better informed treatment decisions.

Home | Healthcare Professionals | FreeStyle | Abbott

Nicorette

Nicorette® (nicotine) has been at the forefront of Nicotine Replacement Therapy (NRT) innovation for more than 40 years, and now has a wide range of smoking cessation products including gum, lozenge, patch, inhalator and sprays. In 2023, Nicorette® QuickMist Mouthspray became the first and only medicinal aid licensed for vaping cessation. Visit our stand for HCP resources and tools.

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk. Adverse events should also be reported to McNeil Products Limited on 0808 238 9999.


References: 1. Nicorette QuickMist 1mg/spray Mouthspray SmPc

Click here for Nicorette® prescribing information

Pregnancy Sickness Support

Pregnancy Sickness Support is the only registered charity in the UK providing support and information to those suffering with any level of Nausea and Vomiting in pregnancy as well as it’s severest form, Hyperemesis Gravidarum. We provide Empathy, Expertise and Support to sufferers, their families and healthcare professionals throughout the UK. We offer a helpline which can be accessed by a freephone number or via WhatsApp alongside which we have an extensive network of volunteers who provide peer support to those currently suffering.
For more information about the support available, visit the website.

Website

Takeda

Takeda is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to
discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the
planet. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetics and Hematology,
Neuroscience, and Gastroenterology (GI), with expertise in immune and inflammatory diseases. We also make
targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly
innovative medicines that contribute to making a difference in people’s lives by advancing the frontier of new
treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust,
modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working
with our partners in health care in approximately 80 countries and regions.
Additional information about Takeda UK Ltd. is available through its corporate website,
www.takeda.com/en-gb.

Orion Pharma

Orion Pharma (UK) Ltd. is a wholly owned subsidiary of Orion Corporation, pharmaceutical company based in Finland. Our principal role is to represent Orion's pharmaceutical products in the UK across a range of therapy areas including Respiratory, Women’s Health and Neurological Disorders.

In the spirit of the values which are common to all units and employees of the Group, we endeavour to provide innovative medicinal treatments and best quality service to patients, healthcare professionals and the community in the UK, the region we operationally cover.

We are continuously developing new drugs and treatment methods. The core therapy areas of our pharmaceutical R&D are oncology and pain.​ We collaborate closely with healthcare professionals and leading global research institutions and pharmaceutical companies.
www.orionpharma.co.uk

Enteromed

Enteromed Ltd is a Clinical Research Organisation working closely with top gastroenterologists to support intestinal adsorbents as a safe first line treatment for gastrointestinal disorders, through scientific and clinical research. This UK company was established in 2014 and is also an importer and distributor of gastrointestinal medical devices. Our aim is bringing safe and effective OTC treatments containing intestinal adsorbents to the UK market and helping people with gastrointestinal disorders. Enterosgel® is a safe and effective product that has been available world-wide for over 20 years, and clinically proven in recent UK studies to treat symptoms of acute diarrhoea and irritable bowel syndrome with diarrhoea (IBS-D), from newborns to the elderly.

Hello Fresh

HelloFresh is a German meal-kit company that delivers pre-portioned ingredients and recipes directly to customers' doorstep. The company was founded in November 2011 by Dominik Richter, Thomas Griesel, and Jessica Nilsson, and is headquartered in Berlin, Germany. HelloFresh offers a variety of meal plans to suit different dietary preferences and needs. Customers can choose from the Classic Plan, which includes a variety of meat and fish dishes, the Veggie Plan for vegetarian options, and the Family Plan designed for families with kid-friendly recipes. Each week, customers can select from a range of 20 recipes, and HelloFresh delivers all the necessary ingredients in the right quantity, along with step-by-step cooking instructions. Since its inception, HelloFresh has expanded its operations globally and now operates in several countries across Europe, North America, Asia, and Oceania. The company has established subsidiaries in Australia, Belgium, Canada, France, Germany, the Netherlands, New Zealand, Sweden, Switzerland, the United Kingdom, and the United States. Additionally, HelloFresh has also formed partnerships with various grocery chains to expand its distribution network. HelloFresh is a dominant player in the meal-kit industry, holding a significant market share. The company's global sales have experienced substantial growth over the years, reaching €3.75 billion in 2020. Despite stiff competition from other meal-kit providers, HelloFresh has managed to maintain a strong position due to its focus on quality ingredients, convenience, and a wide range of recipe options. Throughout its journey, HelloFresh has witnessed significant milestones. In 2017, the company went public and was listed on the Frankfurt Stock Exchange. It has also made strategic acquisitions to enhance its offerings, such as the purchase of Green Chef in the USA and Chefs Plate in Canada. As of the latest updates, HelloFresh continues to expand its presence in existing markets and explore opportunities in new territories. The company remains focused on delivering high-quality meal-kits, promoting sustainability, and further improving its customer experience. With its innovative approach to meal preparation and delivery, HelloFresh has revolutionized the way people cook at home, becoming a household name in many countries.

Nursing and Midwifery Council

We're the independent regulator of more than 808,000 nurses, midwives and nursing associates. Our vision is safe, effective and kind nursing and midwifery practice for everyone.